Related Experiment Video
Updated: May 13, 2026

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
Diane E Rushlow1, Berber M Mol, Jennifer Y Kennett
1Impact Genetics and the Toronto Western Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Background:
Retinoblastoma is the childhood retinal cancer that defined tumour-suppressor genes. Previous work shows that mutation of both alleles of the RB1 retinoblastoma suppressor gene initiates disease. We aimed to characterise non-familial retinoblastoma tumours with no detectable RB1 mutations.
Methods:
Of 1068 unilateral non-familial retinoblastoma tumours, we compared those with no evidence of RB1 mutations (RB1(+/+)) with tumours carrying a mutation in both alleles (RB1(-/-)). We analysed genomic copy number, RB1 gene expression and protein function, retinal gene expression, histological features, and clinical data.
Findings:
No RB1 mutations (RB1(+/+)) were reported in 29 (2·7%) of 1068 unilateral retinoblastoma tumours. 15 of the 29 RB1(+/+) tumours had high-level MYCN oncogene amplification (28-121 copies; RB1(+/+)MYCN(A)), whereas none of 93 RB1(-/-) primary tumours tested showed MYCN amplification (p<0·0001). RB1(+/+)MYCN(A) tumours expressed functional RB1 protein, had fewer overall genomic copy-number changes in genes characteristic of retinoblastoma than did RB1(-/-) tumours, and showed distinct aggressive histological features. MYCN amplification was the sole copy-number change in one RB1(+/+)MYCN(A) retinoblastoma. One additional MYCN(A) tumour was discovered after the initial frequencies were determined, and this is included in further analyses. Median age at diagnosis of the 17 children with RB1(+/+)MYCN(A) tumours was 4·5 months (IQR 3·5-10), compared with 24 months (15-37) for 79 children with non-familial unilateral RB1(-/-) retinoblastoma.
Interpretation:
Amplification of the MYCN oncogene might initiate retinoblastoma in the presence of non-mutated RB1 genes. These unilateral RB1(+/+)MYCN(A) retinoblastomas are characterised by distinct histological features, only a few of the genomic copy-number changes that are characteristic of retinoblastoma, and very early age of diagnosis.
Funding:
National Cancer Institute-National Institutes of Health, Canadian Institutes of Health Research, German Research Foundation, Canadian Retinoblastoma Society, Hyland Foundation, Toronto Netralaya and Doctors Lions Clubs, Ontario Ministry of Health and Long Term Care, UK-Essen, and Foundations Avanti-STR and KiKa.
Insights
MYCN oncogene amplification may initiate retinoblastoma in children with intact RB1 genes. These tumors show distinct features and an early diagnosis age.
Area of Science:
- Oncology
- Genetics
- Ophthalmology
Background:
- Retinoblastoma, a childhood retinal cancer, is linked to tumor-suppressor genes.
- RB1 gene mutations initiate retinoblastoma.
- This study investigates retinoblastoma tumors without RB1 mutations.
Purpose of the Study:
- To characterize non-familial retinoblastoma tumors with no detectable RB1 mutations.
- To compare these tumors with those carrying RB1 mutations.
Main Methods:
- Analyzed 1068 unilateral non-familial retinoblastoma tumors.
- Compared tumors with no RB1 mutations (RB1(+/+)) to those with both alleles mutated (RB1(-/-)).
- Assessed genomic copy number, gene expression, protein function, histology, and clinical data.
Main Results:
- 2.7% of tumors (RB1(+/+)) lacked RB1 mutations.
- 15 of these RB1(+/+) tumors showed MYCN oncogene amplification (RB1(+/+)MYCN(A)).
- RB1(+/+)MYCN(A) tumors had functional RB1 protein, fewer genomic changes, distinct histology, and earlier diagnosis (median 4.5 months) compared to RB1(-/-) tumors (median 24 months).
Conclusions:
- MYCN oncogene amplification may initiate retinoblastoma in the presence of functional RB1 genes.
- RB1(+/+)MYCN(A) retinoblastomas exhibit unique histological features and genomic profiles.
- These tumors are associated with a significantly earlier age of diagnosis.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation